PubMed:19389916
Annnotations
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 310-511 | DRI_Background | denotes | Understanding what influences the serum activity of these enzymes as well as the sources of these enzymes is important to interpreting the significance of alterations in enzyme activity during disease. |
T2 | 512-605 | DRI_Outcome | denotes | This article demonstrates that in the mouse and human the predominant XylT in serum is XylT2. |
T3 | 782-924 | DRI_Outcome | denotes | In addition, the data from Xylt2 knock-out mice and mice with liver neoplasia show that liver is a significant source of serum XylT2 activity. |
T4 | 925-1088 | DRI_Outcome | denotes | The data presented suggest that serum XylT levels may be an informative biomarker in patients who suffer from diseases affecting platelet and/or liver homeostasis. |
PMID_GLOBAL
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 850-859 | DiseaseOrPhenotypicFeature | denotes | neoplasia | 0005070 |
Glycosmos6-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 757-762 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
T2 | 757-762 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
T3 | 844-849 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
T4 | 870-875 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
T5 | 1070-1075 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-168 | Sentence | denotes | Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum. |
TextSentencer_T2 | 169-309 | Sentence | denotes | Circulating glycosyltransferases including xylosyltransferases I (XylT1) and II (XylT2) are potential serum biomarkers for various diseases. |
TextSentencer_T3 | 310-511 | Sentence | denotes | Understanding what influences the serum activity of these enzymes as well as the sources of these enzymes is important to interpreting the significance of alterations in enzyme activity during disease. |
TextSentencer_T4 | 512-605 | Sentence | denotes | This article demonstrates that in the mouse and human the predominant XylT in serum is XylT2. |
TextSentencer_T5 | 606-781 | Sentence | denotes | Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro. |
TextSentencer_T6 | 782-924 | Sentence | denotes | In addition, the data from Xylt2 knock-out mice and mice with liver neoplasia show that liver is a significant source of serum XylT2 activity. |
TextSentencer_T7 | 925-1088 | Sentence | denotes | The data presented suggest that serum XylT levels may be an informative biomarker in patients who suffer from diseases affecting platelet and/or liver homeostasis. |
T1 | 0-168 | Sentence | denotes | Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum. |
T2 | 169-309 | Sentence | denotes | Circulating glycosyltransferases including xylosyltransferases I (XylT1) and II (XylT2) are potential serum biomarkers for various diseases. |
T3 | 310-511 | Sentence | denotes | Understanding what influences the serum activity of these enzymes as well as the sources of these enzymes is important to interpreting the significance of alterations in enzyme activity during disease. |
T4 | 512-605 | Sentence | denotes | This article demonstrates that in the mouse and human the predominant XylT in serum is XylT2. |
T5 | 606-781 | Sentence | denotes | Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro. |
T6 | 782-924 | Sentence | denotes | In addition, the data from Xylt2 knock-out mice and mice with liver neoplasia show that liver is a significant source of serum XylT2 activity. |
T7 | 925-1088 | Sentence | denotes | The data presented suggest that serum XylT levels may be an informative biomarker in patients who suffer from diseases affecting platelet and/or liver homeostasis. |
T1 | 0-168 | Sentence | denotes | Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum. |
T2 | 169-309 | Sentence | denotes | Circulating glycosyltransferases including xylosyltransferases I (XylT1) and II (XylT2) are potential serum biomarkers for various diseases. |
T3 | 310-511 | Sentence | denotes | Understanding what influences the serum activity of these enzymes as well as the sources of these enzymes is important to interpreting the significance of alterations in enzyme activity during disease. |
T4 | 512-605 | Sentence | denotes | This article demonstrates that in the mouse and human the predominant XylT in serum is XylT2. |
T5 | 606-781 | Sentence | denotes | Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro. |
T6 | 782-924 | Sentence | denotes | In addition, the data from Xylt2 knock-out mice and mice with liver neoplasia show that liver is a significant source of serum XylT2 activity. |
T7 | 925-1088 | Sentence | denotes | The data presented suggest that serum XylT levels may be an informative biomarker in patients who suffer from diseases affecting platelet and/or liver homeostasis. |
DisGeNET
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T0 | 809-814 | gene:64132 | denotes | Xylt2 |
T1 | 850-859 | disease:C0027651 | denotes | neoplasia |
T2 | 809-814 | gene:64132 | denotes | Xylt2 |
T3 | 850-859 | disease:C1882062 | denotes | neoplasia |
T4 | 909-914 | gene:64132 | denotes | XylT2 |
T5 | 850-859 | disease:C0027651 | denotes | neoplasia |
T6 | 909-914 | gene:64132 | denotes | XylT2 |
T7 | 850-859 | disease:C1882062 | denotes | neoplasia |
R1 | T0 | T1 | associated_with | Xylt2,neoplasia |
R2 | T2 | T3 | associated_with | Xylt2,neoplasia |
R3 | T4 | T5 | associated_with | XylT2,neoplasia |
R4 | T6 | T7 | associated_with | XylT2,neoplasia |
GlycoBiology-FMA
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T1 | 96-105 | FMAID:62851 | denotes | platelets |
_T2 | 96-105 | FMAID:167145 | denotes | platelets |
_T3 | 162-167 | FMAID:167330 | denotes | serum |
_T4 | 271-276 | FMAID:167330 | denotes | serum |
_T5 | 344-349 | FMAID:167330 | denotes | serum |
_T6 | 590-595 | FMAID:167330 | denotes | serum |
_T7 | 651-656 | FMAID:167330 | denotes | serum |
_T8 | 701-707 | FMAID:162307 | denotes | plasma |
_T9 | 740-749 | FMAID:167145 | denotes | platelets |
_T10 | 740-749 | FMAID:62851 | denotes | platelets |
_T11 | 757-762 | FMAID:256053 | denotes | blood |
_T12 | 844-849 | FMAID:93672 | denotes | liver |
_T13 | 844-849 | FMAID:7197 | denotes | liver |
_T14 | 870-875 | FMAID:7197 | denotes | liver |
_T15 | 870-875 | FMAID:93672 | denotes | liver |
_T16 | 903-908 | FMAID:167330 | denotes | serum |
_T17 | 957-962 | FMAID:167330 | denotes | serum |
_T18 | 1054-1062 | FMAID:167145 | denotes | platelet |
_T19 | 1054-1062 | FMAID:62851 | denotes | platelet |
_T20 | 1070-1075 | FMAID:7197 | denotes | liver |
_T21 | 1070-1075 | FMAID:93672 | denotes | liver |
uniprot-human
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-21 | http://www.uniprot.org/uniprot/Q9H1B5 | denotes | Xylosyltransferase II |
uniprot-mouse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-21 | http://www.uniprot.org/uniprot/Q9EPL0 | denotes | Xylosyltransferase II |
T2 | 809-814 | http://www.uniprot.org/uniprot/Q9EPL0 | denotes | Xylt2 |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 850-859 | http://purl.bioontology.org/ontology/NCBITAXON/217470 | denotes | neoplasia |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 350-375 | http://purl.obolibrary.org/obo/GO_0003824 | denotes | activity of these enzymes |
T2 | 480-495 | http://purl.obolibrary.org/obo/GO_0003824 | denotes | enzyme activity |
T3 | 757-771 | http://purl.obolibrary.org/obo/GO_0007596 | denotes | blood clotting |
T4 | 763-771 | http://purl.obolibrary.org/obo/GO_0050817 | denotes | clotting |
T5 | 1076-1087 | http://purl.obolibrary.org/obo/GO_0042592 | denotes | homeostasis |
T6 | 1076-1087 | http://purl.obolibrary.org/obo/GO_0033484 | denotes | homeostasis |
UBERON-AE
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 162-167 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
T2 | 271-276 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
T3 | 344-349 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
T4 | 590-595 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
T5 | 651-656 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
T6 | 903-908 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
T7 | 957-962 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
T8 | 757-762 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T9 | 757-771 | http://purl.obolibrary.org/obo/UBERON_0010210 | denotes | blood clotting |
T10 | 844-849 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
T11 | 870-875 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
T12 | 1070-1075 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
GlycoBiology-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 757-762 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
T2 | 757-762 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
T3 | 844-849 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
T4 | 870-875 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
T5 | 1070-1075 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
performance-test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 844-849 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
PD-UBERON-AE-B_T2 | 870-875 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
PD-UBERON-AE-B_T3 | 1070-1075 | http://purl.obolibrary.org/obo/UBERON_0002107 | denotes | liver |
PD-UBERON-AE-B_T4 | 757-762 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
PD-UBERON-AE-B_T5 | 162-167 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T6 | 271-276 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T7 | 344-349 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T8 | 590-595 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T9 | 651-656 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T10 | 903-908 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T11 | 957-962 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
PD-UBERON-AE-B_T12 | 757-771 | http://purl.obolibrary.org/obo/UBERON_0010210 | denotes | blood clotting |
Anatomy-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 757-762 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
T3 | 844-849 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |
T4 | 870-875 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |
T5 | 1070-1075 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 850-859 | Phenotype | denotes | neoplasia | HP:0002664 |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 850-859 | Disease | denotes | neoplasia | http://purl.obolibrary.org/obo/MONDO_0005070 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 550-555 | OrganismTaxon | denotes | mouse | 10088|10090 |
T3 | 560-565 | OrganismTaxon | denotes | human | 9606 |
T4 | 645-650 | OrganismTaxon | denotes | human | 9606 |
T5 | 825-829 | OrganismTaxon | denotes | mice | 10088 |
T6 | 834-838 | OrganismTaxon | denotes | mice | 10088 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 96-105 | Body_part | denotes | platelets | http://purl.obolibrary.org/obo/CL_0000233 |
T2 | 701-707 | Body_part | denotes | plasma | http://purl.obolibrary.org/obo/UBERON_0001969 |
T3 | 740-749 | Body_part | denotes | platelets | http://purl.obolibrary.org/obo/CL_0000233 |
T4 | 757-762 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T5 | 844-849 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
T6 | 870-875 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
T7 | 1054-1062 | Body_part | denotes | platelet | http://purl.obolibrary.org/obo/CL_0000233 |
T8 | 1070-1075 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
CL-cell
Id | Subject | Object | Predicate | Lexical cue | cl_id |
---|---|---|---|---|---|
T1 | 96-105 | Cell | denotes | platelets | http://purl.obolibrary.org/obo/CL:0000233 |
T2 | 740-749 | Cell | denotes | platelets | http://purl.obolibrary.org/obo/CL:0000233 |
T3 | 1054-1062 | Cell | denotes | platelet | http://purl.obolibrary.org/obo/CL:0000233 |